ProCE Banner Activity

Updates in Metastatic Prostate Cancer Care: Expert Guidance for Multidisciplinary Community Practice and VHA Systems

Slideset Download

Review expert perspectives in this regularly updated slideset for guidance on optimal community and VHA care of patients with metastatic prostate cancer, including patient selection, deciding among approved regimens, and managing toxicities.

Released: April 07, 2023



Daniel P. Petrylak

Daniel P. Petrylak, MD

Professor of Medicine (Medical Oncology) and of Urology
Director, Prostate and GU Medical Oncology
Yale Cancer Center
New Haven, Connecticut

David VanderWeele

David VanderWeele, MD, PhD

Associate Professor
Department of Hematology/Oncology
Northwestern University
Attending Physician
Department of Hematology/Oncology
Jesse Brown VA Medical Center
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by educational grants from Astellas, AstraZeneca Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc., Merck Sharp & Dohme Corp, and Sanofi Genzyme.


AstraZeneca Pharmaceuticals

Bayer HealthCare Pharmaceuticals Inc.

Sanofi Genzyme